Search by Drug Name or NDC

    NDC 54859-0702-60 Conex 2; 60 mg/1; mg/1 Details

    Conex 2; 60 mg/1; mg/1

    Conex is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION. The primary component is DEXBROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE.

    Product Information

    NDC 54859-0702
    Product ID 54859-702_21a5aaa5-eb19-425d-b026-47efa1c04bdc
    Associated GPIs 43993002540310
    GCN Sequence Number 001153
    GCN Sequence Number Description dexbrompheniramine/pseudoephed TABLET 2 MG-60 MG ORAL
    HIC3 Z2N
    HIC3 Description 1ST GEN ANTIHISTAMINE AND DECONGESTANT COMBINATION
    GCN 96446
    HICL Sequence Number 000507
    HICL Sequence Number Description DEXBROMPHENIRAMINE MALEATE/PSEUDOEPHEDRINE HCL
    Brand/Generic Generic
    Proprietary Name Conex
    Proprietary Name Suffix n/a
    Non-Proprietary Name Dexbrompheniramine Maleate, Pseudoephedrine HCl
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 2; 60
    Active Ingredient Units mg/1; mg/1
    Substance Name DEXBROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE
    Labeler Name LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION
    Pharmaceutical Class Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2024-12-31

    Package

    NDC 54859-0702-60 (54859070260)

    NDC Package Code 54859-702-60
    Billing NDC 54859070260
    Package 60 TABLET in 1 BOTTLE (54859-702-60)
    Marketing Start Date 2007-11-01
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 82f9f52c-797e-4842-9c9a-40213181d99a Details

    Revised: 12/2020